Derivation and culture of small hepatocyte progenitor cells (SHPCs) capable of proliferating in vitro has been described in rodents and recently in humans. These cells are capable of engrafting in injured livers, however, they display de-differentiated morphology and reduced xenobiotic metabolism activity in culture over passages. Here we report that SHPCs derived from adult primary human hepatocytes (PHHs) and cultured on mouse embryonic fibroblasts (MEFs) not only display differentiated morphology and exhibit gene expression profiles similar to adult PHHs, but importantly, they retain their phenotype over several passages. Further, unlike previous reports, where extensive manipulations of culture conditions are required to convert SHPCs to metabolically functional hepatocytes, SHPCs in our co-culture system maintain expression of xenobiotic metabolism-associated genes. We show that SHPCs in co-culture are able to perform xenobiotic metabolism at rates equal to their parent PHHs as evidenced by the metabolism of acetaminophen to all of its major metabolites. In summary, we present an improved co-culture system that allows generation of SHPCs from adult PHHs that maintain their differentiated phenotype over multiple passages. Our findings would be useful for expansion of limited PHHs for use in studies of drug metabolism and toxicity testing.
Keywords: AFP, alpha-fetoprotein; Drug metabolism; FBS, fetal bovine serum; Hepatocyte transplantation; Liver disease modeling; Liver regeneration; MACS, magnetic-activated cell sorting; MEFs, mouse embryonic fibroblasts; PHHs, primary human hepatocytes; SHPCs, small hepatocyte progenitor cells; SULTs, sulfotransferases; Toxicity testing; UGTs, glucuronosyl tranferases; sECs, sinusoidal endothelial cells.
© 2020 The Authors.